Scientists at the School of Medicine are leading the medical monitoring of a new clinical trial to treat tuberculosis more quickly.
LifeArc and the Infection Group, led by Professor Stephen Gillespie announced a partnership to develop a molecular diagnostic test for the detection and quantification of tuberculosis (TB) bacteria in patients.
the first ever Molecular bacterial load assay (MBLA) stakeholders conference was held at the University of St Andrews, 11th – 13th June 2018.
Experts from around the world are gathered in St Andrews to learn how to dramatically cut the time needed to diagnose tuberculosis to save hundreds of thousands of lives.
The Orbital diagnostics team won the innovation of the year award at the Scottish Enterprise Life Science awards.
The Orbital Diagnostics, which is a spin out company from the School of Medicine, were shortlisted for the Times Higher Education University Innovation of the year for their SLIC technology.
Professor Stephen Gillespie, Sir James Black Chair of Medicine, has been interviewed about tuberculosis for the Lancet Respiratory Medicine World TB day issue that is now available.
Congratulations go to Professor Stephen Gillespie who has been elected to The Royal Society of Edinburgh.
Stephen Gillespie will be convening the Wellcome Trust Sanger Institute on the Advanced Course “Genomics and Clinical Bacteriology” from 22nd-27th January.
Professor Stephen Gillespie recently attended the British Thoracic Winter Conference in London and presented two papers.
- Page 1 of 2